v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Common Stock
At the market offering
Common Stock
Additional Paid-in Capital
At the market offering
Additional Paid-in Capital
Subscription Receivables
Accumulated Deficit
At the market offering
Total
Balance at the beginning (in shares) at Dec. 31, 2023   516,404            
Balance at the beginning at Dec. 31, 2023   $ 4   $ 381,264 $ (60,710) $ (473,602)   $ (153,044)
Net income (loss)           42,005   42,005
Termination of forward purchase agreements         $ 60,710     60,710
Issuance of shares and reclassification of liability related to cashless warrant exercises shares   27,310            
Issuance of shares and reclassification of liability related to cashless warrant exercises value       14,979       14,979
Issuance of common stock, shares 2,241 5,556         2,241  
Issuance of common stock, value     $ 147 384     $ 147 384
Stock-based compensation expense shares   4,000            
Stock-based compensation expense       6,250       6,250
Balance at the ending (in shares) at Dec. 31, 2024   555,511            
Balance at the ending at Dec. 31, 2024   $ 4   403,024   (431,597)   (28,569)
Net income (loss)           (39,222)   $ (39,222)
Issuance of shares and reclassification of liability related to cashless warrant exercises shares   11,064,517           27,310
Issuance of shares and reclassification of liability related to cashless warrant exercises value   $ 5   7,039       $ 7,044
Issuance of common stock, shares 218,419 267,455         218,419  
Issuance of common stock, value     $ 168 235     $ 168 235
Stock-based compensation expense       5,317       5,317
Balance at the ending (in shares) at Dec. 31, 2025   12,105,902            
Balance at the ending at Dec. 31, 2025   $ 9   $ 415,783   $ (470,819)   $ (55,027)